Payment Policy Update: Beginning September 1, 2026, Virginia Cancer Specialists will no longer accept cash. Read more here..
FAIRFAX, Va., August 26, 2026 /PRNewswire/ — Virginia Cancer Specialists, ranked #1 practice in Virginia for cancer care and across all medical specialties by Castle Connolly, is pleased to welcome Kai-Li Liang, MD. Dr. Liang is a board certified medical oncologist and clinical investigator whose expertise will further strengthen one of the region’s most advanced and comprehensive cancer research programs.
Dr. Liang completed fellowship training in Medical Oncology at Johns Hopkins University School of Medicine after serving as Chief Resident and completing his residency in Internal Medicine at Johns Hopkins Bayview Medical Center. Dr. Liang earned his medical degree from Stony Brook University School of Medicine and his bachelor’s degree in microbiology from the University of Maryland.
Dr. Liang joins Virginia Cancer Specialists at a pivotal time of growth for the practice’s research and clinical trials program. With the largest community-based oncology clinical trials portfolio in the Mid-Atlantic region, Virginia Cancer Specialists continues to expand patient access to groundbreaking therapies. Dr. Liang’s arrival enhances Virginia Cancer Specialists’ ability to bring next-generation therapies to patients closer to home through participation in leading national and international clinical trials.
“Virginia Cancer Specialists has long been recognized as a leader in community-based cancer research, and we are thrilled to welcome Dr. Liang to our team,” said Alex Spira MD, PhD, FACP, FASCO, Co-Director of the Virginia Cancer Specialists Research Institute and a nationally recognized clinical investigator. “His passion for advancing cancer treatment through clinical research aligns perfectly with our mission to bring the most innovative therapies directly to patients. As we continue expanding our research platform, Dr. Liang will play an important role in helping us accelerate access to the latest treatment opportunities throughout the region.”
Virginia Cancer Specialists has been at the forefront of research advancement for decades, providing patients with access to clinical trials that may not otherwise be available in the community setting. The practice collaborates with leading pharmaceutical companies, cooperative research groups, and academic institutions to evaluate emerging therapies across a broad spectrum of cancer types.
“I’m excited to be joining the team at Virginia Cancer Specialists and to help bring next generation cancer therapies to patients,” said Dr. Liang. “Early-phase clinical research is advancing how we treat cancer and I look forward to providing meaningful new options for patients.”
In addition to expanding the research program, Dr. Liang will provide comprehensive cancer care while contributing to the development and execution of clinical studies designed to improve outcomes and quality of life for patients facing cancer.
With 10 locations across Northern Virginia, Virginia Cancer Specialists remains committed to delivering world-class cancer care through a combination of compassionate treatment, multidisciplinary expertise, and a robust research infrastructure that continues to shape the future of oncology.
Kai-Li Liang, MD, Medical Oncologist
About Virginia Cancer Specialists
Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, has been recognized as the #1 physician practice in Virginia in cancer care and across all medical specialties for 3 years running (2024-2026), as recognized by Castle Connolly Top Doctors. It features a world-class treatment team offering access to the most current treatment protocols fighting cancer and blood diseases. It’s also home to the Virginia Cancer Specialists Research Institute and the largest clinical trials portfolio in the Mid-Atlantic – including a dedicated research facility for Phase I clinical trials and later-stage trials through a joint venture with Fairfax’s NEXT Oncology. The practice offers medical oncology, radiation oncology, musculoskeletal tumor surgery, breast surgery, thoracic surgery, genetic counseling, support cancer care, financial counseling, onsite laboratory, onsite pharmacy, language services, telehealth, nurse advice line, and much more. Virginia Cancer Specialists is part of The US Oncology Network. This collaboration unites the practice with more than 600 sites of care across 31 states, 2,700 affiliated physicians, and research and data from thousands of patients with cancer in clinical trials across the country. Through its collaboration with Sarah Cannon Research Institute, Virginia Cancer Specialists offers access to a comprehensive menu of clinical studies and has contributed to pivotal research that has led to the approval of new cancer therapies. For more information about The US Oncology Network, which is supported by McKesson, a trusted name and global leader in healthcare for over 180 years, visit USOncology.com. For more information about Virginia Cancer Specialists, visit: VirginiaCancerSpecialists.com
Media Contact
Jean Dzierzak
Jean.Dzierzak@USOncology.com
703-963-5770
